[Value of prevention of congenital toxoplasmosis].
OBJECTIVE
To verify incidence of toxoplasmosis seroconversion during pregnancy and the interest of treating the mother.


METHODS
Among 7044 infants born between January 1989 and December 1993, 78 (1.1%) born to mothers who developped toxoplasmosis seroconversion during pregnancy were followed.


RESULTS
Among 69 mothers treated, there were only 9 cases of congenital toxoplasmosis (13.4%) including only 3 cases of patent toxoplasmosis.


CONCLUSIONS
Treating the mother is an effective means of preventing toxoplasmosis. The cost of verifying seronegativity in women during pregnancy could be reduced by primary prevention.
Douche
C
C
Service d'Ophtalmologie, Centre Hospitalier, Montreuil.
Benabdesselam
A
A
Mokhtari
F
F
Le Mer
Y
Y
D003049:Coccidiostats / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000188:drug therapy* / Q000276:immunology; D012307:Risk Factors; D012698:Serologic Tests; D014123:Toxoplasmosis / Q000188:drug therapy* / Q000276:immunology; D014125:Toxoplasmosis, Congenital / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control*
D003049:Coccidiostats
Intérêt de la prévention de la toxoplasmose congénitale.